Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription 12.09.2022 2 Am Heart J 2 Am J Cardiol 1 Am J Crit Care 4 Am J Med 4 Angiology 2 Atherosclerosis 1 Cardiovasc Res 1 Catheter Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 1 Circ J 3 Circ Res 1 Circulation 3 Clin Cardiol 1 Dtsch Med Wochenschr 12 Eur Heart J 1 Hypertension 1 Int J Cardiol 4 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 2 J Clin Endocrinol Metab 1 J Clin Invest 5 JAMA 2 Mayo Clin Proc 1 N Engl J Med 2 PLoS One 1 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. KAPUR NK, Kim RJ, Moses JW, Stone GW, et al
   Primary Left Ventricular Unloading with Delayed Reperfusion in Patients with Anterior ST-Elevation Myocardial Infarction: Rationale and Design of the STEMI-DTU Randomized Pivotal Trial.
   Am Heart J. 2022 Sep 1. pii: S0002-8703(22)00184.
   PubMed         Abstract available
   
   
2. GARCIA H, Springer B, Vengrenyuk A, Krishnamoorthy P, et al
   Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project.
   Am Heart J. 2022;253:30-38.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

3. RADAIDEH Q, Abusnina W, Ponamgi S, Al-Abdouh A, et al
   Meta-Analysis of Use of Pulmonary Artery Catheter and Mortality in Patients With Cardiogenic Shock on Mechanical Circulatory Support.
   Am J Cardiol. 2022;180:165-166.
   PubMed        
   
   
4. NAJJAR SN, Dweck BE, Nair A, Birnbaum Y, et al
   Relation of T Wave Positivity in Lead aVR to Ischemic Etiology of Cardiomyopathy.
   Am J Cardiol. 2022;180:17-23.
   PubMed         Abstract available
   
   

   
   Am J Crit Care

5. SUBA S, Woo N, Dzikowicz DJ, Kozik TM, et al
   Value of a 12-Lead Electrocardiogram for Assessing P Waves.
   Am J Crit Care. 2022;31:431-432.
   PubMed        
   
   

   
   Am J Med

6. MURPHY A, Goldberg S
   Mechanical complications of myocardial infarction.
   Am J Med. 2022 Sep 5. pii: S0002-9343(22)00629.
   PubMed         Abstract available
   
   
7. ALPERT J
   Should we continue to administer beta blockers to patients with an acute myocardial infarction?
   Am J Med. 2022 Sep 2. pii: S0002-9343(22)00644.
   PubMed        
   
   
8. ONG GJ, Sellers A, Mahadavan G, Nguyen TH, et al
   "Bushfire Season" in Australia: Determinants of increases in risk of acute coronary syndromes and Takotsubo Syndrome.
   Am J Med. 2022 Sep 1. pii: S0002-9343(22)00634.
   PubMed         Abstract available
   
   
9. CHEN B, Collen LV, Mowat C, Isaacs KL, et al
   Inflammatory bowel disease and cardiovascular diseases.
   Am J Med. 2022 Sep 1. pii: S0002-9343(22)00633.
   PubMed         Abstract available
   
   

   
   Angiology

10. HE Y, Huang M, Li Z, Cheng Q, et al
    Association of Serum gamma-Glutamyltransferase With C-Reactive Protein Levels in Patients With Coronary Heart Disease.
    Angiology. 2022 Sep 6:33197221121013. doi: 10.1177/00033197221121013.
    PubMed         Abstract available
    
    
11. AKBOGA MK, Inanc IH, Sabanoglu C, Akdi A, et al
    Systemic Immune-Inflammation Index and C-Reactive Protein/Albumin Ratio Could Predict Acute Stent Thrombosis and High SYNTAX Score in Acute Coronary Syndrome.
    Angiology. 2022 Sep 7:33197221125779. doi: 10.1177/00033197221125779.
    PubMed         Abstract available
    
    
12. DONG H, Wang J, Hu P, Lu N, et al
    Association of Apolipoprotein A1, High Density Lipoprotein Cholesterol, and Their Ratio with Inflammatory Marker in Chinese Adults with Coronary Artery Disease.
    Angiology. 2022 Sep 6:33197221121002. doi: 10.1177/00033197221121002.
    PubMed         Abstract available
    
    
13. SUWANNASOM P, Phinyo P, Leemasawat K, Chichareon P, et al
    Prognostic Value of Ankle-Brachial Index in Prediction of Cardiovascular Events in an Asian Population with Multiple Atherosclerotic Risk Factors.
    Angiology. 2022 Sep 3:33197221124772. doi: 10.1177/00033197221124772.
    PubMed         Abstract available
    
    

    
    Atherosclerosis

14. KUMAR R, Bainey KR
    Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?
    Atherosclerosis. 2022;355:45-47.
    PubMed        
    
    
15. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
    Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
    Atherosclerosis. 2022;355:52-59.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

16. LIU T, Meng Z, Liu J, Li J, et al
    Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells.
    Cardiovasc Res. 2022 Sep 5. pii: 6692411. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

17. AHLERS MJ, Srivastava PK, Basir MB, O'Neill WW, et al
    Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30390.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

18. ZHENG R, Xu Y, Li M, Lu J, et al
    Examining the Linear Association Between Blood Pressure Levels and Cardiovascular Diseases in the Absence of Major Risk Factors in China.
    Circ Cardiovasc Qual Outcomes. 2022 Sep 6:101161CIRCOUTCOMES121008774.
    PubMed         Abstract available
    
    

    
    Circ J

19. FUJITA H
    Cloud-Based Prehospital Electrocardiography May Save More ST-Segment-Elevation Myocardial Infarction Patients in Regional Medical Systems.
    Circ J. 2022 Sep 7. doi: 10.1253/circj.CJ-22-0528.
    PubMed        
    
    

    
    Circ Res

20. NAKAYAMA Y, Mukai N, Kreitzer G, Patwari P, et al
    Interaction of ARRDC4 With GLUT1 Mediates Metabolic Stress in the Ischemic Heart.
    Circ Res. 2022;131:510-527.
    PubMed         Abstract available
    
    
21. PRAG HA, Aksentijevic D, Dannhorn A, Giles AV, et al
    Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury.
    Circ Res. 2022;131:528-541.
    PubMed         Abstract available
    
    
22. SCHULZ R, Heusch G
    Targeted Mito- and Cardioprotection by Malonate.
    Circ Res. 2022;131:542-544.
    PubMed        
    
    

    
    Circulation

23. HADLEY MB, Henderson SB, Brauer M, Vedanthan R, et al
    Protecting Cardiovascular Health From Wildfire Smoke.
    Circulation. 2022;146:788-801.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

24. VALENTINE CM, Chazal RA
    Essential nonclinical competencies for cardiovascular specialists imperatives for training.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23914.
    PubMed         Abstract available
    
    
25. YAO H, Guo Q, Cheng Y, Zhu T, et al
    Predictors and morphological properties of culprit healed plaques in patients with angina pectoris.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23896.
    PubMed         Abstract available
    
    
26. YI M, Cao Q, Tang WH, Liu Q, et al
    Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23899.
    PubMed         Abstract available
    
    

    
    Dtsch Med Wochenschr

27. FICHERA CF, Furnau G
    [Mechanical Assist Devices in Cardiogenic Shock Complicating Myocardial Infarction].
    Dtsch Med Wochenschr. 2022;147:1182-1187.
    PubMed         Abstract available
    
    

    
    Eur Heart J

28. VERGALLO R, Pedicino D
    Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?
    Eur Heart J. 2022 Sep 6. pii: 6692466. doi: 10.1093.
    PubMed        
    
    
29. CREA F
    Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease.
    Eur Heart J. 2022;43:3087-3091.
    PubMed        
    
    
30. NADARAJAH R, Wu J, Hurdus B, Asma S, et al
    The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
    Eur Heart J. 2022;43:3164-3178.
    PubMed         Abstract available
    
    
31. SPIRITO A, Cao D, Mehran R
    Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
    Eur Heart J. 2022;43:3145-3147.
    PubMed        
    
    
32. LANCELLOTTI P, Go YY, Nchimi A
    Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg?
    Eur Heart J. 2022;43:3129-3131.
    PubMed        
    
    
33. DRIESSEN RS, van Diemen PA, Raijmakers PG, Knuuti J, et al
    Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.
    Eur Heart J. 2022;43:3118-3128.
    PubMed         Abstract available
    
    
34. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    PubMed         Abstract available
    
    
35. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed         Abstract available
    
    
36. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    PubMed         Abstract available
    
    
37. GUEDENEY P, Thiele H, Collet JP
    Timing of invasive management of NSTE-ACS: is the time up for early management?
    Eur Heart J. 2022;43:3161-3163.
    PubMed        
    
    
38. HESS CN, Bonaca MP
    Risk of remnants and remnant risk in peripheral artery disease.
    Eur Heart J. 2022;43:3270-3272.
    PubMed        
    
    
39. MARQUINA C, Lacaze P, Tiller J, Riaz M, et al
    Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
    Eur Heart J. 2022;43:3243-3254.
    PubMed         Abstract available
    
    

    
    Hypertension

40. JONES DW, Clark D 3rd, Morgan TO, He FJ, et al
    Potassium-Enriched Salt Substitution as a Population Strategy to Prevent Cardiovascular Disease.
    Hypertension. 2022;79:2199-2201.
    PubMed        
    
    

    
    Int J Cardiol

41. SIMONI AH, Frydenlund J, Kragholm KH, Boggild H, et al
    Socioeconomic inequity in incidence, outcomes and care for acute coronary syndrome: A systematic review.
    Int J Cardiol. 2022;356:19-29.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

42. KOVACIC JC, Fuster V
    Exercise, Cardiovascular Disease, and the Athlete's Heart.
    J Am Coll Cardiol. 2022;80:1088-1090.
    PubMed        
    
    
43. TUCKER WJ, Fegers-Wustrow I, Halle M, Haykowsky MJ, et al
    Exercise for Primary and Secondary Prevention of Cardiovascular Disease: JACC Focus Seminar 1/4.
    J Am Coll Cardiol. 2022;80:1091-1106.
    PubMed         Abstract available
    
    
44. ANTONIADES C, Polkinghorne MD
    Novel Biomarkers for Risk Stratification in NSTE-ACS: Is There a Place for Cathepsin S?
    J Am Coll Cardiol. 2022;80:1011-1013.
    PubMed        
    
    
45. ANDERSON HVS, Masri SC, Abdallah MS, Chang AM, et al
    2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05033.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

46. CHEN JY, Li T, Wang JL, Wang ZL, et al
    Protective Effects and Mechanisms of Melatonin on Stress Myocardial Injury in Rats.
    J Cardiovasc Pharmacol. 2022;80:417-429.
    PubMed         Abstract available
    
    
47. JI M, Li Y, Liu Y, Ma G, et al
    Vaspin Ameliorates Cardiac Remodeling by Suppressing Phosphoinositide 3-Kinase/Protein Kinase B Pathway to Improve Oxidative Stress in Heart Failure Rats.
    J Cardiovasc Pharmacol. 2022;80:442-452.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

48. WEI H, Zhao M, Wu J, Li C, et al
    Association of Systemic Trimethyllysine with Heart Failure with Preserved Ejection Fraction and Cardiovascular Events.
    J Clin Endocrinol Metab. 2022 Sep 5. pii: 6691858. doi: 10.1210.
    PubMed         Abstract available
    
    
49. LI Y, Gao R, Zhao B, Zhang Y, et al
    Low serum bicarbonate levels increased the risk of all-cause, cardiovascular and cancer Mortality in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692819. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

50. BLANCO-DOMINGUEZ R, de la Fuente H, Rodriguez C, Martin-Aguado L, et al
    CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.
    J Clin Invest. 2022 Sep 6. pii: 152418. doi: 10.1172/JCI152418.
    PubMed         Abstract available
    
    

    
    JAMA

51. JAMES MT, Har BJ, Tyrrell BD, Faris PD, et al
    Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial.
    JAMA. 2022;328:839-849.
    PubMed         Abstract available
    
    
52. SLOMSKI A
    Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes.
    JAMA. 2022;328:817.
    PubMed        
    
    
53. RABER L, Koskinas KC
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction-Reply.
    JAMA. 2022;328:891-892.
    PubMed        
    
    
54. BENSON VM
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:890-891.
    PubMed        
    
    
55. CALDERON AT, Sanz-Sanchez J, Garcia-Garcia HM
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:891.
    PubMed        
    
    

    
    Mayo Clin Proc

56. SAHAI SK, Balonov K, Bentov N, Bierle DMM, et al
    Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.
    Mayo Clin Proc. 2022;97:1734-1751.
    PubMed         Abstract available
    
    
57. DAFAALLA M, Rashid M, Van Spall HGC, Mehta L, et al
    Women Are Less Likely to Survive AMI Presenting With Out-of-Hospital Cardiac Arrest: A Nationwide Study.
    Mayo Clin Proc. 2022;97:1608-1618.
    PubMed         Abstract available
    
    

    
    N Engl J Med

58. KOO BK, Hu X, Kang J, Zhang J, et al
    Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI.
    N Engl J Med. 2022;387:779-789.
    PubMed         Abstract available
    
    

    
    PLoS One

59. CHAMBERGO-MICHILOT D, Atamari-Anahui N, Segura-Saldana P, Branez-Condorena A, et al
    Trends and geographical variation in mortality from coronary disease in Peru.
    PLoS One. 2022;17:e0273949.
    PubMed         Abstract available
    
    
60. NAZLI SA, Chua YA, Mohd Kasim NA, Ismail Z, et al
    Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.
    PLoS One. 2022;17:e0273896.
    PubMed         Abstract available
    
    

    
    Thromb Haemost

61. RIKKEN SAOF, Storey RF, Andreotti F, Clemmensen P, et al
    Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
    Thromb Haemost. 2022 Sep 8. doi: 10.1055/s-0042-1753479.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: